- Home
- About
- Editorial Team
- Browse
- Submissions
- Advertising
- ESMINT Website
The Journal of the Swiss Society of
Minimally Invasive Neurological Therapy
The Journal of the Swiss Society of
Minimally Invasive Neurological Therapy
Swiss association of Minimally Invasive Neurological Therapy provides a unique platform for further knowledge in all aspects of minimally invasive neurological therapy for neuroradiologists and associated professionals through electronic publication of quality peer-reviewed articles that lead to the highest standards in patient care, research and education, and to promote discussion of these and other issues through its electronic activities.
Swiss association of Minimally Invasive Neurological Therapy aims to be internationally recognized as a focused primary source of information regarding all aspects of minimally invasive neurological therapy for all professionals engaged in these and related fields. Continued optimisation of delivery will enable Swiss association of Minimally Invasive Neurological Therapy to impact and enhance patient care, research, therapy, training, and life-long learning.
Swiss association of Minimally Invasive Neurological Therapy Features
Conflicts of interest and/or disclosure statements (if applicable) must be completed during the electronic submission process. Each author must verify authorship and declare conflicts before the paper will be assigned to an editor so please be sure you have up to date email addresses for each author listed on the manuscript. Disclosure is not intended to prevent authors with potential conflicts of interest from contributing to Swiss association of Minimally Invasive Neurological Therapy; rather, it places on record any relationship that may exist with mentioned or competing products or firms. Authors are responsible for notifying the Journal of financial arrangements including but not limited to agreements for research support (including provision of equipment or materials), speaker bureaus, consulting or ownership interests. It is important that disclosure statements be updated promptly to reflect any new relationships that arise after the initial submission of the manuscript.
Swiss association of Minimally Invasive Neurological Therapy is committed to protecting the rights of research participants and subjects and requires authors to adhere to the ethical principles outlined in the 1964 Declaration of Helsinki and later amendments (revised 2013). Swiss association of Minimally Invasive Neurological Therapy also requires authors to affirm that Institutional Review Board/Ethics Approval Committee approval has been granted or waived for all research studies involving human and/or animal subjects. A patient consent statement is required for all submitted manuscripts and in the event experimental animals are included, authors must include a section in Methods to confirm that appropriate measures were taken to minimize pain or discomfort, including an outline of animal care. Finally, all manuscripts must include one of the following statements before the Conflict of Interest statement:
We declare that our study adheres to the ethical principles outlined in the 1964 Declaration of Helsinki and later amendments. We declare that this study has been approved by the [insert appropriate ethics committee] and all patients or their representatives gave informed consent prior to enrollment.
We declare that this study followed the Guide for the Care and Use of Laboratory Animals (the Guide, NRC 2011) as well as [insert specific country laws if applicable].
or
We declare that this manuscript does not contain clinical investigations or participant data.
Swiss association of Minimally Invasive Neurological Therapy publishes fully peer-reviewed Original Research papers, Technical Notes, Editorials, invited Review Articles and Letters to the Editor. Subject matter covers the spectrum of interventional neuroradiology and related minimally invasive therapy.
Submitted manuscripts will be evaluated initially by the Editor-in-Chief and an Associate Editor. A rapid initial decision of whether to have a manuscript formally reviewed by two or more reviewers with appropriate expertise or rejected without a formal review will be determined by the senior editor and a second reviewer (Associate Editor, Section Editor, Editorial Board member, or invited reviewer with topic-related expertise) based on the quality, originality, scientific rigor, and data presentation/analysis of the manuscript. The Editor-in-Chief has full authority over the entire editorial content of Swiss association of Minimally Invasive Neurological Therapy journal and the publication timing of said content.
The editors invite submission of manuscripts that have major importance to the scientific community. To be considered for expedited publication, an article must be unique and contain information that could make a significant difference in medical practice or constitute an important advance in basic knowledge. The authors must clearly state reasons for the expedited request in the cover letter. If the editors agree that an article should be an expedited publication, they will arrange an accelerated review and, if accepted, accelerated publication.
Everything Swiss association of Minimally Invasive Neurological Therapy publishes is freely available online throughout the world for you to read, download, copy, distribute, and use (with attribution) in any way you wish. No permission is required.
An Open Access Publication is one that meets the following two conditions:
The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access; a license to copy, use, distribute, transmit, and display the work publicly; and to make and distribute derivative works in any digital medium for any responsible purpose subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for personal use.
A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organisation that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
Published research results and ideas are the foundation for future progress in science and medicine. Open Access publishing therefore leads to wider dissemination of information and increased efficiency in science. As a researcher, publishing in an Open Access journal allows anyone with an interest in your work to read it: that translates into increased usage and impact.
Swiss association of Minimally Invasive Neurological Therapy applies the Creative Commons Attribution License (CCAL) to all works we publish (read the human-readable summary or the full license legal code). Under CCAL, authors retain ownership of the copyright for their article; however, authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles, so long as the original authors and source are cited. No permission is required from the authors or the publishers.
In most cases, appropriate attribution can be provided by simply citing the original article. If the item you plan to reuse is not part of a published article (e.g., a featured issue image), then please indicate the originator of the work and the volume, issue, and date of the journal in which the item appeared. For any reuse or redistribution of a work, you must also make clear the license terms under which the work was published.
This broad license was developed to facilitate open access to, and free use of, original works of all types. Applying this standard license to your own work will ensure your right to make your work freely and openly available.
© Copyright ESMINT
Unless explicitly stated otherwise, all rights including those in copyright in the content of this website are owned by or controlled by ESMINT. IP of scientific content belongs to the author mentioned.
The content of this site may not be copied, reproduced, republished, downloaded, posted, broadcast or transmitted in any way without the prior written consent by ESMINT or the copyright owner / IP owner.
For further information about our information and data policies please see the ESMINT Constitution and Privacy Policy.
This privacy policy applies to your use of the Journal (collectively referred to as the “Journal”), operated by The Swiss Society for Minimally Invasive Neurologically Therapy, a Swiss-based not-for-profit corporation, referred to interchangeably hereafter as “ESMINT”.
The “Journal” includes, without limitation, the Swiss association of Minimally Invasive Neurological Therapy website and any other online platforms used by ESMINT which could require your personal data. ESMINT respects your privacy and is committed to protecting the confidentiality of your personal information. This policy explains how ESMINT collects and uses Member, customer and site visitor information, and how it protects your privacy.
This policy applies to personal information held about individuals. It does not apply to information ESMINT holds about companies and other organisations. It is in addition to any specific policies concerning specific products or services. It does not supersede the ESMINT terms and conditions which govern the use of the ESMINT Website. ESMINT reserves the right to amend this privacy policy at its sole discretion, without prior notice, at any time, with the proviso that details of the amendments are published on the Swiss association of Minimally Invasive Neurological Therapy Web Site. They become effective from the time of posting. ESMINT is the sole owner of the Website and as such is the sole owner of any information collected through the Website. ESMINT is committed to the following standards, on a commercially reasonable basis:
To access Swiss association of Minimally Invasive Neurological Therapy will require you to register as a user and to receive our authorisation before you can use those particular features. Whether you are an individual or a corporation, partnership, or other form of commercial enterprise, in order for you obtain our authorisation to use those features and to be considered a registered user, you may be required to provide us with certain information about you or your business and, if a business, any or all individuals you designate to represent that business in connection with your use of the Website (e.g. names, addresses, e-mail addresses, telephone numbers, and other Personally Identifiable Information of each individual who will use the Website). Once we have authorised you as a registered user, we may provide you with a customer identification number and you will select a unique username and password.
If you are submitting information on behalf of others for registration purposes or otherwise, you represent that you have their permission, agreement and full authorization to provide this information to us. We reserve the right (a) to ask you to provide evidence of your authority at any time during, or even after, the submission process and (b) to contact those individuals to confirm your authority at any time. If we determine that your authority has not been properly obtained, we may immediately and without notice to you discontinue your authorised use of those features of the Website for which you have registered.
As a general rule, to enable ESMINT to correctly identify you, to provide you with the products and services you have requested and to communicate with you, the following minimum information must be provided in order for your order, request, application, etc. to be processed:
Other personal information may be requested to help identification (eg date of birth, nationality by country, etc.) or to enable ESMINT to understand your profile so you can be provided with better and more appropriate products and services (eg Professional Interests and Topics of Interest).
Credit Card information, along with other information related to specific transactions, is not collected at the time of your order, request or application, and is used only for the purposes of that particular transaction. For your protection, the Credit Card information is only entered in an external window of the credit card service provider. The record of the transaction is kept for 10 years for legal and audit reasons (except Credit Card information). ESMINT takes every precaution to ensure that this information is stored in a safe location and that it cannot be accessed by unauthorised parties.
For your convenience and security, your email address is unique to you in the system. (ESMINT does not permit two different persons to have the same email address in the system). You are strongly recommended to use an email address which is personal to you and that is not shared with others. This is to ensure that communications which are sent to you personally are not read by others, and that others do not gain access to the information in your ‘My ESMINT’ account. Furthermore, ESMINT may use your email address to communicate with you about value added products linked either to your membership or your congress attendance.
Your unique email permits automated retrieval of your login details, which are sent to your personal email address.
Personal information is needed by ESMINT to enable it to properly manage its member and customer files. These files are used to enable ESMINT to fulfil its role in providing a wide range of services to its members, contributors and customers. The personal information which you supply may be specifically used to:
Listed below are some of the security procedures that ESMINT uses to protect your privacy:
ESMINT respects the privacy of personal email addresses and complies with the current legislation on email communication (according to the Swiss Data Protection Act and the Tele Service Data Protection Act). The objective is not to send you unwanted messages, and your email details will not be passed on to any other individual or organisation without your explicit permission except in the case of conference/meeting registration – see Registration Terms and Conditions. Without your specific ok to receive e-campaigns from ESMINT you may receive emails concerning:
You can manage the extent to which ESMINT communicates with you by using the 'My Alerts' tab in your ‘MY ACCOUNT’ pages. If you decide that you do wish to receive email communications from ESMINT you can select which categories of news interest you. All mailings categories offer you the possibility to unsubscribe by deselecting the alert category. If you indicate that you do not wish to receive ESMINT generated emails you will only receive emails directly related to the transactions you have with ESMINT (eg confirmation of registration, membership renewal, etc.) and other necessary individual communications.
ESMINT complies with Swiss and EC directives (Switzerland and the Swiss data protection legislation are both recognized to be compliant with EC Directive 95/46/EC) and takes all reasonable care to prevent any unauthorised access to your personal data. ESMINT staff and contractors have a responsibility to keep your information confidential.
ESMINT may supply your information to its contractors to perform specific services (such as to the publishers to deliver ESMINT journals, etc.). Otherwise, ESMINT does not disclose personal information to any other person or organisation without your consent.
To protect your information, ESMINT uses an industry standard security protocol called Secure Sockets Layer (SSL) to encrypt the transmission of sensitive information between you and our website. SSL is used, for example, when you login or when you make a credit card payment. To know if transmissions are encrypted, look for the lock on your web browser or check that the URL starts with https://. Despite ESMINT’s efforts to protect your personal data, there is always some risk that an unauthorized third party may find a way around our security systems or that transmissions of information over the Internet will be intercepted. ESMINT is not responsible or liable for any loss or damage of any sort arising from or relating to any breach of our security or interception of your transmissions (see Terms of Use).
Cookies are pieces of information that a website transfers to your computer’s hard disk for record keeping purposes. They are small text files that a website can use to recognise repeat users and facilitate their ongoing access to, and use of, the site. They do not pose a threat to your system or files. The use of cookies is an industry standard, and many websites use them to provide useful features. Cookies in and of themselves do not personally identify users. Most browsers are set initially to accept cookies. You can set your computer to reject cookies. However, if you do choose to disable cookies, you will not be able to enjoy the full range of online services available through the ‘My ESMINT’ area.
As a website gathers individual pieces of Non-Personal Information from its users, it may combine similar data from many or all the users of the website into one big “batch”. This sort of statistical information is called aggregate data because it reflects the habits and characteristics of a large group of anonymous people. Websites may use aggregate data or share it with business partners so that the information and services they provide best meet the needs of the users. Aggregate data also helps advertisers and sponsors on the Web know how effectively they are reaching and meeting the needs of their target audience. Click Stream Information. A record of all the pages you have visited during your visit to a particular website or the services you accessed from the site or from an email. Click Stream Information is associated with your browser and not with you personally. It records the archives of your browser.
If you have any further questions about the ESMINT Privacy and Security Policy or its implementation, or if at any time you believe that ESMINT has not adhered to the principles stated in this Policy, please contact us by sending us an email at .
Swiss association of Minimally Invasive Neurological Therapy publishes fully peer-reviewed Original Research papers, invited Review Articles, Technical Notes, Editorials, and Letters to the Editor. Therefore, submitted articles which are biased in reference to companies’ products and services will be not accepted and published. Swiss association of Minimally Invasive Neurological Therapy will not accept advertisements intended to be juxtaposed with editorial content on the same product. All advertisements will be clearly identifiable as advertisements. Editors have full and final authority for approving advertisements and for enforcing advertising policy. Swiss association of Minimally Invasive Neurological Therapy will not carry advertisements for products proven to be seriously harmful to health.